NCT00355121 - Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL® | Biotech Hunter

Enrollment

882

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

July 31, 2009

Conditions

Meningococcal MeningitisTetanusDiphtheriaPertussisPoliomyelitis

Interventions

BIOLOGICAL

Polysaccharide Diphtheria Toxoid Conjugate Vaccine

0.5 mL IM of each vaccine. (DAPTACEL® + IPOL on Day 0 and Menactra on Day 30)

BIOLOGICAL

Polysaccharide Diphtheria Toxoid Conjugate Vaccine

0.5 mL, IM of each vaccine. (DAPTACEL® + Menactra® on Day 0 and IPOL on Day 30)

BIOLOGICAL

Polysaccharide Diphtheria Toxoid Conjugate Vaccine

0.5 mL, IM of each vaccine (Menactra® + IPOL on Day 0 and DAPTACEL® on Day 30)

Trial Locations (26)

13210

Syracuse

14620

Rochester

15241

Pittsburgh

18960

Sellersville

23510

Norfolk

30062

Layton, UT 84041

30322

Atlanta

37660

Kingsport

40004

Bardstown

43205

Columbus

44118

University Heights

44308

Akron

45229

Cincinnati

63044

Bridgeton

63141

St Louis

72205

Little Rock

80304

Boulder

84041

Layton

84062

Pleasant Grove

84095

South Jordan

84123

Salt Lake City

84405

Ogden

84604

Provo

87108

Albuquerque

99220

Spokane

01801

Woburn